I agree, Smokey. The language clearly states that RECRUITMENT and DOSING are proceeding well. One can hardly say that there is delay with that verbiage. Additionally, opening another site just makes the recruitment process easier. I also agree that the language is specifically chosen to "update" but release no specifics on the trial. I think it was a fair way to update the market without reporting as they have in the past, which they specifically said they wouldn't.
- Forums
- ASX - By Stock
- BLT
- Ann: FOURTH SITE IN HEPATITIS C CLINICAL TRIAL
Ann: FOURTH SITE IN HEPATITIS C CLINICAL TRIAL, page-7
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online